Paper28129253
HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa.
Kityo C and 14 others. J Acquir Immune Defic Syndr, 2017. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa. Papers, record 28129253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28129253
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| Drug Resistance, Viral | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| Reverse Transcriptase Inhibitors | Major topic |
| Adult | |
| Africa South of the Sahara | |
| Antiretroviral Therapy, Highly Active | |
| CD4 Lymphocyte Count | |
| Female | |
| HIV Reverse Transcriptase | |
| Humans | |
| Male | |
| Middle Aged | |
| Mutation | |
| Treatment Failure | |
| Viral Load |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed | PubMed | ||
| 001 | World Health Organization | International | PubMed | PubMed | |
| MC_UU_12023/23 | Medical Research Council | United Kingdom | PubMed | PubMed | |
| U01 AI069911 | NIAID NIH HHS | United States | U01AI069911 | PubMed and NIH | NIH RePORTER |
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16890837 | The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. | Lancet | 2006 | https://conductscience.org/library/papers/16890837 | PubMed |
| 2 | 24998532 | Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review. | J Int AIDS Soc | 2014 | https://conductscience.org/library/papers/24998532 | PubMed |
| 3 | 16076886 | An automated genotyping system for analysis of HIV-1 and other microbial sequences. | Bioinformatics | 2005 | https://conductscience.org/library/papers/16076886 | PubMed |
| 4 | 26807968 | Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing. | AIDS | 2016 | https://conductscience.org/library/papers/26807968 | PubMed |
| 5 | 23687292 | Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine. | J Infect Dis | 2013 | https://conductscience.org/library/papers/23687292 | PubMed |
| 6 | 19604043 | Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings. | J Infect Dis | 2009 | https://conductscience.org/library/papers/19604043 | PubMed |
| 7 | 19578237 | HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme. | Antivir Ther | 2009 | https://conductscience.org/library/papers/19578237 | PubMed |
| 8 | 21848790 | The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*. | HIV Med | 2012 | https://conductscience.org/library/papers/21848790 | PubMed |
| 9 | 25101529 | 2014 Update of the drug resistance mutations in HIV-1. | Top Antivir Med | 2014 | https://conductscience.org/library/papers/25101529 | PubMed |
| 10 | 24795328 | Drug susceptibility and resistance mutations after first-line failure in resource limited settings. | Clin Infect Dis | 2014 | https://conductscience.org/library/papers/24795328 | PubMed |
| 11 | 20964479 | Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy. | AIDS Res Hum Retroviruses | 2011 | https://conductscience.org/library/papers/20964479 | PubMed |
| 12 | 23727942 | Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study period. | AIDS | 2013 | https://conductscience.org/library/papers/23727942 | PubMed |
| 13 | 23991055 | High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa. | PLoS One | 2013 | https://conductscience.org/library/papers/23991055 | PubMed |
| 14 | 19417582 | The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. | AIDS | 2009 | https://conductscience.org/library/papers/19417582 | PubMed |
| 15 | 22842995 | Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies. | AIDS | 2013 | https://conductscience.org/library/papers/22842995 | PubMed |
| 16 | 22474222 | Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies. | Clin Infect Dis | 2012 | https://conductscience.org/library/papers/22474222 | PubMed |
| 17 | 22403431 | Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool. | J Clin Microbiol | 2012 | https://conductscience.org/library/papers/22403431 | PubMed |
| 18 | 20163340 | Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1. | Curr HIV Res | 2010 | https://conductscience.org/library/papers/20163340 | PubMed |
| 19 | 27732929 | No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom. | J Infect Dis | 2016 | https://conductscience.org/library/papers/27732929 | PubMed |
| 20 | 20188624 | Using of nevirapine is associated with intermediate and reduced response to etravirine among HIV-infected patients who experienced virologic failure in a resource-limited setting. | J Clin Virol | 2010 | https://conductscience.org/library/papers/20188624 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41482685 | Regional Variations of Rates and Determinants of Drug Resistance Mutations in People Failing First-line Therapy for HIV-1: A Substudy from the D2EFT Phase 3b/4 Clinical Trial. | Clin Infect Dis | 2026 | https://conductscience.org/library/papers/41482685 | PubMed |
| 39339151 | Etravirine Prevents West Nile Virus and Chikungunya Virus Infection Both In Vitro and In Vivo by Inhibiting Viral Replication. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39339151 | PubMed |
| 38020274 | Genotypic resistance testing improves antiretroviral treatment outcomes in a cohort of adolescents in Cameroon: Implications in the dolutegravir-era. | J Public Health Afr | 2023 | https://conductscience.org/library/papers/38020274 | PubMed |
| 35854413 | A Case Report of Multiclass HIV Drug-Resistance After an Inappropriate Switch of ARVs with Persistent Unsuppressed Viral Load. | J Int Assoc Provid AIDS Care | 2022 | https://conductscience.org/library/papers/35854413 | PubMed |
| 35458459 | Pre-Treatment Integrase Inhibitor Resistance and Natural Polymorphisms among HIV-1 Subtype C Infected Patients in Ethiopia. | Viruses | 2022 | https://conductscience.org/library/papers/35458459 | PubMed |
| 34741609 | Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria. | J Antimicrob Chemother | 2022 | https://conductscience.org/library/papers/34741609 | PubMed |
| 32119691 | HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals. | PLoS One | 2020 | https://conductscience.org/library/papers/32119691 | PubMed |
| 32005262 | Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda. | AIDS Res Ther | 2020 | https://conductscience.org/library/papers/32005262 | PubMed |
| 31969438 | Long-Acting Rilpivirine (RPV) Preexposure Prophylaxis Does Not Inhibit Vaginal Transmission of RPV-Resistant HIV-1 or Select for High-Frequency Drug Resistance in Humanized Mice. | J Virol | 2020 | https://conductscience.org/library/papers/31969438 | PubMed |
| 30977467 | Evolution of HIV-1 drug resistance after virological failure of first-line antiretroviral therapy in Lusaka, Zambia. | Antivir Ther | 2019 | https://conductscience.org/library/papers/30977467 | PubMed |
| 30304061 | HIV-genetic diversity and drug resistance transmission clusters in Gondar, Northern Ethiopia, 2003-2013. | PLoS One | 2018 | https://conductscience.org/library/papers/30304061 | PubMed |
| 30053052 | Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes. | J Antimicrob Chemother | 2018 | https://conductscience.org/library/papers/30053052 | PubMed |
| 30032305 | Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring. | J Antimicrob Chemother | 2018 | https://conductscience.org/library/papers/30032305 | PubMed |
| 29661246 | Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data. | AIDS Res Ther | 2018 | https://conductscience.org/library/papers/29661246 | PubMed |
| 29293156 | HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052. | J Acquir Immune Defic Syndr | 2018 | https://conductscience.org/library/papers/29293156 | PubMed |
| 29283390 | Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in "Real-World" Settings. | Viruses | 2017 | https://conductscience.org/library/papers/29283390 | PubMed |
| 29206999 | Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance. | J Infect Dis | 2017 | https://conductscience.org/library/papers/29206999 | PubMed |
| 29108797 | Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. | Lancet Infect Dis | 2018 | https://conductscience.org/library/papers/29108797 | PubMed |
| 28968669 | Human Immunodeficiency Virus Type 1 Drug Resistance Mutations Update. | J Infect Dis | 2017 | https://conductscience.org/library/papers/28968669 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| MLC1 | 23209 | PubTator's text mining | https://conductscience.org/library/genes/23209 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28129253
GET https://conductscience.org/api/papers/v1/28129253/references?page=2